Video Experimental Relacionado
Updated: Sep 9, 2025
05:59
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
2.5K
Fisiopatología y tratamiento farmacológico de los problemas del sueño en la enfermedad de Parkinson
Cristian Falup-Pecurariu1,2, Larisa Ungureanu1,2, Iulia Murasan2
1Faculty of Medicine, Transilvania University Brasov, Romania.
Journal of Parkinson's disease
|September 2, 2025
Resumen
Los problemas de sueño son comunes en la enfermedad de Parkinson (EP), lo que afecta a la calidad de vida. Comprender los mecanismos del trastorno del sueño PD es clave para desarrollar mejores tratamientos.
Área de la Ciencia:
- Neurología
- Medicina del sueño
- Investigación de la enfermedad de Parkinson
Sus antecedentes:
- Los problemas de sueño son síntomas no motores frecuentes en la enfermedad de Parkinson (EP).
- Estos trastornos incluyen insomnio, trastorno del comportamiento del sueño REM, síndrome de piernas inquietas y somnolencia excesiva durante el día.
- Los problemas de sueño empeoran con la progresión de la EP, afectando la calidad de vida del paciente y otros síntomas.
Objetivo del estudio:
- Revisar las principales alteraciones del sueño en la enfermedad de Parkinson.
- Para explorar conocimientos fisiopatológicos sobre los trastornos del sueño relacionados con la EP.
- Discutir las estrategias terapéuticas actuales y futuras para el manejo de los trastornos del sueño en la EP.
Principales métodos:
- Revisión de la literatura sobre los trastornos del sueño en la enfermedad de Parkinson.
- Análisis de los mecanismos fisiopatológicos propuestos.
- Evaluación de las opciones de tratamiento actuales y emergentes.
Principales resultados:
- Los trastornos del sueño son muy frecuentes y diversos en los pacientes con enfermedad de Parkinson.
- Los mecanismos incluyen neurodegeneración, disfunción de los neurotransmisores, efectos secundarios de los medicamentos y alteración del ritmo circadiano.
- Las opciones actuales de tratamiento para los trastornos del sueño en la EP son limitadas.
Conclusiones:
- Se necesitan más investigaciones sobre los mecanismos fisiopatológicos para mejorar los objetivos terapéuticos.
- Las estrategias de manejo personalizadas son esenciales para abordar los trastornos del sueño en la enfermedad de Parkinson.
- El desarrollo de tratamientos nuevos y efectivos para los trastornos del sueño en la EP es una necesidad crítica no satisfecha.
Videos de Conceptos Relacionados
01:24Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
01:15Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
01:19Management of Insomnia
320
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
320
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
123
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
123
01:15REM Sleep Behavior Disorder
387
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
387
01:07Narcolepsy
197
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
197